- Reuters•22 minutes ago
A top-30 investor in Swiss pharmaceutical company Actelion (ATLN.S) said he would back a takeover approach for the whole company from U.S. rival Johnson & Johnson (JNJ.N) above 246 Swiss francs. Actelion confirmed it was in talks with J&J on Nov. 25, without giving details. Media reports suggested an initial bid of 246 Swiss francs had been rejected, while subsequent reports have suggested a revised bid of around 250 Swiss francs and the potential for rival companies to also table an offer.
- TheStreet.com•30 minutes ago
U.S. stock futures trade flat following another record close for the Dow; Amazon reportedly envisions opening 2,000 brick-and-mortar grocery stores; Apple Watch sales set a record, Apple CEO says.
- TheStreet.com•4 hours ago
European markets are set for a positive open Tuesday after Asia traders booked their best single day gains in two weeks.
JNJ : Summary for Johnson & Johnson Common Stock - Yahoo Finance
Johnson & Johnson (JNJ)
NYSE - NYSE Real Time Price. Currency in USD
Add to watchlist
|Bid||111.26 x 400|
|Ask||112.70 x 100|
|Day's Range||111.73 - 112.42|
|52 Week Range||94.28 - 126.07|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||19.65|
|Dividend & Yield||3.20 (2.86%)|
|1y Target Est||N/A|